10 bioeconomy bellwethers: earnings season reveals choppy waters in Q3 2017, bullish outlook for 2018
The holiday season has arrived and earnings season too — and here are the highlights for 10 bellwether bioeconomy publicly-traded stocks. Aemetis – ethanol prices dive, but cellulosic on the way Avantium – IPO completed, Synvia next, then Zambezi BioAmber – “bumpy road continues”; cost focus, Sarnia expansion Calyxt – on track for soybean commercial […]












